Amryt Pharma Share Discussion Threads

[barnes4] 20/4/2016 12:25

Agreed JP for once

Management need to steady the ship n fast ha ha

[bigwavedave] 20/4/2016 12:15

Quite right. Thank you divmad.

[soul limbo] 20/4/2016 12:14

alpha.....please put a chart up.... and news box

just edit your first post.... and you'll see options at the bottom....tick the relevant boxes (chart, news, fundamentals etc)

[divmad] 20/4/2016 12:11

"This follows the successful reverse takeover of Fastnet Equity plc by Amryt Pharmaceuticals Designated Activity Company, the renaming of the resulting company as Amryt Pharma plc and a placing of 41,673,402 new ordinary shares at 24 pence per New Ordinary Share to raise £10.0 million (before expenses), which were also completed today".

Straight from yesterday's RNS. Couldn't be clearer.

[bigwavedave] 20/4/2016 11:52

Curry, good point. In this interview Joe Wiley does talk about being delighted at raising the £10m.
4 mins 20 secs in.


But the April 18 statement says it is "proposed." So defo needs clearing up. Must admit that I thought it had been done!

[filterwest] 20/4/2016 11:38

My Barclays have not changed. It is still showing Fastnet. Anyone using Barclay Stockbrokers still showing up Fastnet.

[currypasty] 20/4/2016 11:35

that's just it
"In addition, the Company is proposing to raise £10.0 million"

big difference between got the cash, and proposing!

Im just trying to understand why down so much

filter, my FAST automatically swapped to Amryt shares in my account

[filterwest] 20/4/2016 11:31

I got shares in Fastnet in my Barclays. Does this automatically change to Amryt? Any opinion.

[alphabravo321] 20/4/2016 10:53

This is being dragged down, down 12% on 300k volume? That being said we are on day 2 of the Amryt story...plenty of chapters left

[jacksonpollack] 20/4/2016 10:46

11% down wtf. This want suppose to happen.

[jacksonpollack] 20/4/2016 10:39

Showing as 345 million shares on lse fundamentals.

The Company has since 28 August 2015, been classified as an investing company under Rule 15 of the ESM Rules for Companies ("ESM Rules"). On 30 March 2016 the Company entered into a conditional agreement to acquire the entire issued share capital of Amryt Pharmaceuticals Designated Activity Company ("Amryt") for consideration of £29.6 million to be satisfied by the issue of 123,495,096 consideration shares. In addition, the Company is proposing to raise £10.0 million (before expenses) through a conditional placing of 41,673,402 new ordinary shares (following a capital reorganisation) at 24 pence per new ordinary share ("Placing Price").

Amryt was incorporated in August 2015 as a platform to acquire, build, develop and subsequently monetise a pipeline of patent protected, commercially attractive, proprietary drug candidates targeting best in class performance chosen to meet the orphan drug designation criteria. Since incorporation, Amryt has received investment totalling €2.0 million to finance due diligence on potential target businesses and as working capital. In line with its strategy, Amryt has entered into agreements, conditional, inter alia, on admission, to acquire the entire issued share capital of each of Birken AG, SomPharmaceuticals S.A and Somtherapeutics, Corp. Birken is a revenue generating pharmaceutical development and manufacturing company based in Germany.

The main country of operations will be Ireland.

The acquisition of Amryt constitutes a reverse takeover under the AIM Rules and ESM Rules. As a consequence, the current directors are seeking shareholder approval for the proposals at a general meeting.

Details of securities to be admitted including any restrictions as to transfer of securities (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares)

208,339,631 ordinary shares of 1.0p each ("Ordinary Shares") at a placing price of 24p per Ordinary Share


Capital to be raised on admission (if applicable) and anticipated market capitalisation on admission

Placing of 41,673,402 Ordinary Shares at 24p per Ordinary Share to raise £10.0 million

Approximate market capitalisation of £50.0 million on admission at the Placing Price

Percentage of ESM securities not in public hands on admission

62.6%

Details of any other exchange or trading platform to which the ex securities (or other securities of the company) are or will be admitted or traded
AIM, a market regulated by the London Stock Exchange

Full names and functions of directors and proposed directors (underlining the first name by which each is known or including any other name by which each is known)
Existing Board
Cathal Martin Friel Non-executive Chairman
John Michael Edelson Non-executive Director
Michael Henry Nolan Non-executive Director
Harry Thomas Stratford Non-executive Director

New Board (from Admission)
Harry Thomas Stratford Non-executive Chairman
Joseph (Joe) Amrit Wiley CEO
Rory Peter Nealon CFO/COO
Ray Thomas Stafford Non-executive Director
Anthony James Culverwell Non-executive Director
Cathal Martin Friel Non-executive Director

[currypasty] 20/4/2016 10:25

can anyone point to a statement that the placing HAS BEEN DONE ?

[spuddymadrid] 20/4/2016 10:23

We Have 208339631 shares with 10 million sterling in cash from The placement of 41673402 New shares plus The Cash that fastnet had of circa 15m Euros

[icebreaker] 20/4/2016 10:05

Hi Curry Pasty

I think I have the numbers wrong as JP pointed out.

Google Joe Wiley Amryt interview and he mentions the placing there and how much was raised.

Thanks

IB

[currypasty] 20/4/2016 09:51

where does it say that the £10m has actually been raised?

[jacksonpollack] 20/4/2016 09:48

No Amryt shares bought for £29.9 million and £10 raised from placing so we have 345 million shares with £10 million m/c

[icebreaker] 20/4/2016 09:35

Am I right in thinking we should have £30M in cash now?

£10M from Fastnet Equity and £20M raised pre re-listing?

If so, I make that about 14p cash value!?

[currypasty] 20/4/2016 08:45

Jacks, have you a link to that 2m fund raise

as far as I can see, they keep mentioning a 'proposed' £10m fund raise at 24p has this happened, or still being negotiated.. I guess if it isn't actually done, it wont be at 24p now

[jacksonpollack] 20/4/2016 08:43

Sp down again. No interest by the market or pi's at all.

[alphabravo321] 20/4/2016 08:21

Just have to wait for the RNS' to start, If their form is anything to go by, I would say we wont have to wait too long

[alphabravo321] 20/4/2016 07:20

How do I add a chart?! Any help?